Skip to main content

Patanase Side Effects

Generic name: olopatadine nasal

Medically reviewed by Drugs.com. Last updated on Apr 16, 2023.

Note: This document contains side effect information about olopatadine nasal. Some dosage forms listed on this page may not apply to the brand name Patanase.

Applies to olopatadine nasal: nasal spray.

Serious side effects of Patanase

Along with its needed effects, olopatadine nasal (the active ingredient contained in Patanase) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking olopatadine nasal:

Less common

Rare

Incidence not known

Get emergency help immediately if any of the following symptoms of overdose occur while taking olopatadine nasal:

Symptoms of overdose

Other side effects of Patanase

Some side effects of olopatadine nasal may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Rare

Incidence not known

For Healthcare Professionals

Applies to olopatadine nasal: nasal spray.

General

The most frequently reported side effects were bitter taste, headache, epistaxis, pharyngolaryngeal pain, postnasal drip, cough, urinary tract infection, pyrexia, and rash.[Ref]

Respiratory

Very common (10% or more): Epistaxis (up to 25%), nasal ulceration (up to 10%)

Common (1% to 10%): Pharyngolaryngeal pain, postnasal drip, cough, upper respiratory tract infection

Uncommon (0.1% to 1%): Nasopharyngitis, throat irritation

Postmarketing reports: Nasal discomfort, oropharyngeal pain[Ref]

Nervous system

Very common (10% or more): Taste bitter (up to 12.8%)

Common (1% to 10%): Headache

Uncommon (0.1% to 1%): Somnolence

Frequency not reported: Hyposmia, anosmia

Postmarketing reports: Dizziness, dysgeusia[Ref]

Dermatologic

Common (1% to 10%): Rash[Ref]

Genitourinary

Common (1% to 10%): Urinary tract infection[Ref]

Other

Common (1% to 10%): Pyrexia

Uncommon (0.1% to 1%): Creatine phosphokinase elevated, fatigue, influenza[Ref]

Gastrointestinal

Uncommon (0.1% to 1%): Dry mouth[Ref]

Psychiatric

Frequency not reported: Depression/depression worsened[Ref]

References

1. Product Information. Patanase (olopatadine nasal). Alcon Laboratories Inc. 2008.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.